Symptom scoring systems to diagnose distal polyneuropathy in diabetes: The diabetic neuropathy symptom score

Diabetic Medicine

Volumn 19, Issue 11, 2002, Pages 962-965

  Meijer, J W G ^a,b,c   Smit, A J ^b   Sonderen, E V ^b   Groothoff, J W ^b   Eisma, W H ^b   Links, T P ^b  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Revalidatiecentrum Leijpark   (Netherlands)

Author keywords

Diabetic neuropathy; DNE score; DNS score; Polyneuropathy; Symptom score

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; DIABETIC NEUROPATHY EXAMINATION SCORE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; REPRODUCIBILITY; SCORING SYSTEM; SEMMES WEINSTEIN MONOFILAMENT TEST; STANDARD; VALIDATION PROCESS; VIBRATION PERCEPTION THRESHOLD TEST;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; OBSERVER VARIATION; POLYNEUROPATHIES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; VIBRATION;

EID: 0036432972     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00819.x     Document Type: Article

References (27)

1. Boulton AJM. The pathogenesis of diabetic foot problems: An overview. Diabet Med 1996; 13: s12-s16.
2. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994; 331: 854-860.
3. Consensus Statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988; 11: 592-597.
4. Jaeschke R, Guyatt G, Sacket DL. Users' guides to the medical literature: How to use an article about a diagnostic test. JAMA 1994; 271: 389-391.
5. Dyck PJ. Detection, characterization and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve 1988; 11: 21-32.
6. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA et al. Human diabetic endoneurial sorbitol, fructose and myoinositol related to sural nerve morphometry. Ann Neurol 1980; 6: 590-596.
7. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service JF. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985; 108: 861-880.
8. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC et al. The Rochester diabetic neuropathy study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991; 41: 799-807.
9. Dyck PJ, Karnes J, O'Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology 1986; 36: 1300-1308.
10. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. Practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-1289.
11. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993; 16: 1187-1189.
12. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
13. Meijer JWG, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH et al. Diabetic neuropathy examination: A hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care 2000; 23: 750-753.
14. Birke JA, Sims DS. Plantar sensory threshold in the ulcerative foot. Leprosy Rev 1986; 57: 261-267.
15. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes Weinstein Monofilaments: A simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diab Res Clin Pract 1991; 13: 63-68.
16. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower extremity complications: Use of Semmes Weinstein monofilaments. Phys Ther 1996; 76: 68-71.
17. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 289-292.
18. Goldberg JM, Lindblom U. Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neur, Neurosurg Psych 1979; 42: 793-803.
19. Bloom S, Till S, Sonksen P, Smith S. Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects. BMJ 1984; 288: 1793-1795.
20. Young MJ, Breddy L, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibratory perception thresholds. Diabetes Care 1994; 17: 557-560.
21. Hanley JA, McNeil BJ. A method of comparing the areas under the receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
23. Altman DG, ed.Practical Statistics for Medical Research. London: Chapman & Hall, 1997.
24. Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM. Preventive foot care in people with diabetes. Diabetes Care 1998; 21: 2161-2177.
25. Valk GD, Nauta JJP, Strijers RLM, Bertelsman FW. Clinical examination versus neurophysiological examination in the diagnosis of diabetic polyneuropathy. Diabet Med 1992; 9: 716-721.
26. Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JTM. Numbness of the feet is a poor indicator for polyneuropathy in type 2 diabetic patients. Diabet Med 2000; 17: 105-110.
27. Valk GD, Grootenhuis PA, Bouter LM, Bertelsmann FW. Complaints of neuropathy related to the clinical and neurophysiological assessment of nerve function in patients with diabetes mellitus. Diab Res Clin Pract 1994; 26: 29-34.